Jury Still Out on Anthracyclines in HER2+ Breast CancerJury Still Out on Anthracyclines in HER2+ Breast Cancer

Dr Sara Tolaney highlights studies in HER2-positive breast cancer from SABCS 2015, including the less-than-definitive 10-year results of the BCIRG 006 study. Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news